Brandinium

Trademark search for:

BIREPATH

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2010-02-19 — Application filed
  • 2010-04-08 — Limitation of goods/services from ib entered
  • 2010-04-08 — Sn assigned for sect 66a appl from ib
  • 2010-04-09 — Application filed
  • 2010-04-13 — Application filed
  • 2010-05-25 — Approved for pub - principal register
  • 2010-05-25 — Assigned to examiner
  • 2010-06-10 — Assigned to lie
  • 2010-06-10 — Law office publication review completed
  • 2010-06-23 — Notice of publication
  • 2010-07-13 — Published for opposition
  • 2010-09-28 — Registered-principal register
  • 2017-05-05 — Cancelled section 71
  • 2018-01-05 — Total invalidation of reg ext protection created
  • 2018-01-22 — Total invalidation of reg ext protection sent to ib
  • 2018-01-22 — Invalidation processed
  • 2018-02-23 — Total invalidation processed by the ib
  • 2020-02-19 — Final status recorded
  • 2021-05-29 — Death of international registration
  • 2021-05-29 — Notification of effect of cancellation of intl reg mailed
  • 2021-07-06 — Undeliverable mail - no action taken

Owner Information

Takeda Pharmaceutical Company Limited
Osaka 540-8645 JP
Takeda Pharmaceutical Company Limited
Osaka 540-8645 JP
Takeda Pharmaceutical Company Limited
Osaka 540-8645 JP

Correspondent

TAKAHASHI Shuichi c/o Intellectual Property Department,
12-10, Nihonbashi 2-chome,
Chuo-ku
Tokyo 103-8668,

Filing Details

Filing Date:
2010-02-19
Status Date:
2020-02-19
Category:
Pharmaceuticals
Filing Year:
2010

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.